Month: March 2019

Sterna Biologicals Holds Scientific Advisory Board Meeting at 14th Congress of ECCO to Advance Phase IIb Clinical Development Program of SB012 in Ulcerative Colitis

- Meeting included international key opinion leaders - Input provided on SB012 development plan and phase IIb trial protocol MARBURG,...

Easton Announces Filing of Its Financial Statements for the Year Ended December 31, 2018 with a Revenue Increase of 145% Over 2017 and Provides General Business Update

AXT107 Restores Healthy, Non-Leaky Vasculature in the Eye by Inhibiting VEGFR2 and Activating Tie2, the Two Clinically Validated Pathways in Diseases of the Retina

AXT107 exhibited a dual mechanism of action as a monotherapy, disrupting a key component of the Vascular Endothelial Growth Factor...

error: Content is protected !!